Anhar Abdelaziem

Prof. Dr. Anhar Abdelaziem

Chemistry, Al Azhar University, Cairo, Al Qāhirah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MSMariam T. Sayed
Mariam T. Sayed
SESalwa A. Elsharabasy
Salwa A. Elsharabasy
AAAnhar Abdelaziem
Anhar Abdelaziem
Microbial infections are currently a widespread disease in hospitals and community health centres and are a major cause of death worldwide. In pursuit of searching new antimicrobial agents, coumarin linked to thiazoles, pyridines and pyrazoles have been developed and evaluated for their antimicrobial properties against two Gram + bacteria, two Gram − bacteria as well as two fungi. Some of the prepared coumarins displayed high to moderate activity against the tested microorganisms with respect to the reference drugs. However, compound 3 exhibited antimicrobial effect equal to the reference drug Ciprofloxacin for Gram − baceria Enterobacter cloacae. Compound 12 was found to be the most potent compound against Bacillus pumilis with MIC of 7.69 (µmol/ml). Compounds 3, 4 and 12 showed remarkable activity against Streptococcus faecalis with MIC of 14.34, 3.67 and 15.36 (µmol/ml), respectively. Regarding Escherichia coli, most compounds recorded high to moderate MIC values (4.73–45.46 µmol/ml). Moreover, in case of E. cloacae compound 9 was the most potent compound with MIC value of 22.76 (µmol/ml).

20 April 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GAGhada E. Ahmed
Ghada E. Ahmed
ZEZeinab A. Elshahid
Zeinab A. Elshahid
EEEslam Reda El-Sawy
Eslam Reda El-Sawy
MAMohamed S. Abdel-Aziz
Mohamed S. Abdel-Aziz
AAAnhar Abdelaziem
Anhar Abdelaziem
Coumarins are heterocycles of great interest in the development of valuable active structures in chemistry and biological domains. The ability of coumarins to inhibit biofilm formation of Gram positive bacterium (Staphylococcus aureus), Gram negative bacterium (Escherichia coli) as well as the methicillin-resistant S. aureus (MRSA) has been previously described. In the present work, new hybrid coumarin-heterocycles have been synthesized via the reaction of coumarin-6-sulfonyl chloride and 6-aminocoumarin with different small heterocycle moieties. The biological efficacy of the new compounds was evaluated towards their ability to inhibit biofilm formation and their anti-inflammatory properties. The antimicrobial activities of the newly synthesized compounds were tested against Gram positive bacterium (S. aureus ATCC 6538), Gram negative bacterium (E. coli ATCC 25922), yeast (Candida albicans ATCC 10231) and the fungus (Aspergillus niger NRRL-A326). Compounds 4d, 4e, 4f, 6a and 9 showed significant MIC and MBC values against S. aureus, E. coli, C. albicans, and methicillin-resistant S. aureus (MRSA) with especial incidence on compound 9 which surpasses all the other compounds giving MIC and MBC values of (4.88 and 9.76 µg/mL for S. aureus), (78.13 and 312.5 µg/mL for E. coli), (9.77 and 78.13 µg/mL for C. albicans), and (39.06 and 76.7 µg/mL for MRSA), respectively. With reference to the antibiofilm activity, compound 9 exhibited potent antibiofilm activity with IC50 of 60, 133.32, and 19.67 µg/mL against S. aureus, E. coli, and MRSA, (respectively) considering the reference drug (neomycin). Out of all studied compounds, the anti-inflammatory results indicated that compound 4d effectively inhibited nitric oxide production in lipopolysaccharide-(LPS-) stimulated RAW264.7 macrophage cells, giving NO% inhibition of 70% compared to Sulindac (55.2%)

6 July 2021 in Molecules
Verified
Journal Article
Open access
PDF file
HAHeba Abo-Salem
Heba Abo-Salem
HSHayam A. Abd El Salam
Hayam A. Abd El Salam
AAAnhar Abdelaziem
Anhar Abdelaziem
MAMohamed S. Abdel-Aziz
Mohamed S. Abdel-Aziz
EEEslam Reda El-Sawy
Eslam Reda El-Sawy
An efficient and simple protocol for the synthesis of a new class of diverse bis(indolyl)pyridines analogues of the marine alkaloid nortopsentin has been reported. A one-pot four-component condensation of 3-cyanocarbomethylindole, various aldehyde, 3-acetylindole, and ammonium acetate in glacial acetic acid led to the formation of 2,6-bis(1H-indol-3-yl)-4-(substituted-phenyl)pyridine-5-carbonitriles. Additionally, 2,6-bis(1H-indol-3-yl)-4-(benzofuran) pyridine-5-carbonitriles were prepared via a one-pot four-component condensation of 3-cyanocarbomethylindole, various N-substituted-indole-3-aldehydes, 2-acetylbenzofuran, and ammonium acetate. The synthesized compounds were evaluated for their ability to inhibit biofilm formation against the Gram-positive bacterial reference strains Staphylococcus aureus ATCC 6538 and the Gram-negative strain Escherichia coli ATCC 25922. Some of the new compounds showed a marked selectivity against the Gram-positive and Gram-negative strains. Remarkably, five compounds 4b, 7a, 7c, 7d and 8e demonstrated good antibiofilm formation against S. aureus and E. coli. On the other hand, the release of reducing sugars and proteins from the treated bacterial strains over the untreated strains was considered to explain the disruption effect of the selected compound on the contact cells of S. aureus and E. coli. Out of all studied compounds, the binding energies and binding mode of bis-indole derivatives 7c and 7d were theoretically the best thymidylate kinase, DNA gyrase B and DNA topoisomerase IV subunit B inhibitors.

26 June 2020 in Synthetic Communications
Verified
Journal Article
Closed access
AAAnhar Abdelaziem
Anhar Abdelaziem
BBBasma Saad Baaiu
Basma Saad Baaiu
AEAwad Wanis Elbazzar
Awad Wanis Elbazzar
FEFakhri Elabbar
Fakhri Elabbar
5-bromosalicylaldehyde (1) was reacted with thiosemicarbazide to afford thiosemicarbazone derivative 2. The latter underwent cyclocondensation upon reaction with α-haloester, α-haloketone as well as hydrazonoyl halides affording 1,3-thiazoles and arylazothiazoles 3-6, respectively. On the other hand, pyrazolyl thiazolyl coumarin derivatives 9a–c and 11a–c was obtained via reaction of hydrazinylthiazole 8 with acetylacetone, trifloroacetylacetone, ethyl acetoacetate and/or arylazoacetylacetone 10a–c, respectively. Furthermore, thiazolotriazine derivative 12 was accomplished via reaction of 8 with ethyl 2-(2-phenylhydrazono)-2-chloroacetate. The structures of the newly prepared compounds were elucidated by spectral data. Eleven of the newly synthesized compounds were screened for their antibacterial activity. The results indicated that, compounds 5a, 5b, 9a, 9c, 11b and 12 were strong active toward Gram-positive bacteria Enterococcus faecalis. Compound 5a was strong active toward Gram-positive bacteria Staphylococcus aureus. Moreover, compounds 9b, 11b, and 12 were strong active toward Gram-negative bacteria Pseudomonas aeruginosa.

1 August 2003 in Phosphorus, Sulfur, and Silicon and the Related Elements
Verified
Journal Article
Closed access
ZIZeinab H. Ismail
Zeinab H. Ismail
SASoad M. Abdel-Gawad
Soad M. Abdel-Gawad
AAAnhar Abdelaziem
Anhar Abdelaziem
MGM. M. Ghorab
M. M. Ghorab
A novel series of the pyrazolo[3,4-d]pyrimidines having biologically active sulfur moieties 3-20 were prepared via reaction of 4-mercapto-1-phenyl-1 H -pyrazolo[3,4-d]pyrimidine 3 with different reagents. Identification of the new compounds was established by elemental analyses, IR, 1 H-NMR, and mass spectral data. Some of the obtained compounds showed the interesting antimicrobial activity comparable to antibiotic chloramphenicol as standard antibacterial agent and Terbinafin as a standard antifungal agent.

20 May 2020 in Polycyclic Aromatic Compounds
Verified
Journal Article
Closed access
AHA. Y. Hassan
A. Y. Hassan
MMM. A. Mohamed
M. A. Mohamed
AAAnhar Abdelaziem
Anhar Abdelaziem
AHA. O. Hussain
A. O. Hussain
5-Amino-1-phenyl-1H-pyrazole-4-carbohydraizde(1) was used as a key to synthesize new imidazopyrazol-5(1H)-one 5, pyrazolopyrimidines 7 and 9. Furthermore, imidazopyrazoles 13, 15, pyrazolopyridine 16 and pyrazolopyrazolopyridopyrimidine 17 were prepared from pyrazoles 10 and 11. The structure of the new compounds was confirmed by spectral data as well as elemental analysis. Some compounds were selected by the national cancer institute NCI (USA) for anticancer activity against different human cancer cell lines. The results indicated that compound 12 exhibited strong anticancer activity toward Renal Cancer UO-31(GI, 42.81%), while compound 3 was strong active against Breast Cancer MCF7 (GI, 49.88%) and moderate against T-47D (GI, 38.15%) cell lines. However, compound 17 showed strong activity against Leukemia CCRF-CEM (GI, 41.37%) and SR (GI, 44.95%), whereas, compound 9 showed weak activity toward all tested cancer cell lines.